Linkage of amino acid variation and evolution of human immunodeficiency virus type 1 gp120 envelope glycoprotein (subtype B) with usage of the second receptor
- PMID: 15045488
- DOI: 10.1007/s00239-003-2555-x
Linkage of amino acid variation and evolution of human immunodeficiency virus type 1 gp120 envelope glycoprotein (subtype B) with usage of the second receptor
Abstract
To clarify the relationship between the amino acid variations of the gp120 of human immunodeficiency virus type 1 (HIV-1) and the chemokine receptors that are used as the second receptor for HIV, we evaluated amino acid site variation of gp120 between the X4 strains (use CXCR4) and the R5 strains (use CCR5) from 21 sequences of subtype B. Our analysis showed that residues 306 and 322 in the V3 loop and residue 440 in the C4 region were associated with usage of the second receptor. The polymorphism at residue 440 is clearly associated with the usage of the second receptor: The amino acid at position 440 was a basic amino acid in the R5 strains, and a nonbasic and smaller amino acid in the X4 strains, while the V3 loop of the X4 strains was more basic than that of the R5 strains. This suggests that residue 440 in the C4 region, which is close to the V3 loop in the three-dimensional structure, is critical in determining which second receptor is used. Analysis of codon frequency suggests that, in almost all cases, the difference at residue 440 between basic amino acids in the R5 strains and nonbasic amino acids in the X4 strains could be due to a single nucleotide change. These findings predict that the evolutionary changes in amino acid residue 440 may be correlated with evolutionary changes in the V3 loop. One possibility is that a change in electric charge at residue 440 compensates for a change in electric charge in the V3 loop. The amino acid polymorphism at position 440 can be useful to predict the cell tropism of a strain of HIV-1 subtype B.
Similar articles
-
Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism.J Virol. 1999 Jul;73(7):5520-6. doi: 10.1128/JVI.73.7.5520-5526.1999. J Virol. 1999. PMID: 10364300 Free PMC article.
-
On the Physicochemical and Structural Modifications Associated with HIV-1 Subtype B Tropism Transition.AIDS Res Hum Retroviruses. 2016 Aug;32(8):829-40. doi: 10.1089/AID.2015.0373. Epub 2016 Jun 1. AIDS Res Hum Retroviruses. 2016. PMID: 27071630 Free PMC article.
-
Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.J Virol. 2003 Dec;77(24):13376-88. doi: 10.1128/jvi.77.24.13376-13388.2003. J Virol. 2003. PMID: 14645592 Free PMC article.
-
Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures.Retrovirology. 2016 May 3;13(1):32. doi: 10.1186/s12977-016-0266-9. Retrovirology. 2016. PMID: 27143130 Free PMC article.
-
[Sequence variation of HIV and bioinformatics].Uirusu. 2004 Jun;54(1):33-8. doi: 10.2222/jsv.54.33. Uirusu. 2004. PMID: 15449902 Review. Japanese.
Cited by
-
Immunogenicity of a polyvalent HIV-1 candidate vaccine based on fourteen wild type gp120 proteins in golden hamsters.BMC Immunol. 2006 Oct 31;7:25. doi: 10.1186/1471-2172-7-25. BMC Immunol. 2006. PMID: 17076905 Free PMC article.
-
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection.Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18514-9. doi: 10.1073/pnas.0504658102. Epub 2005 Dec 9. Proc Natl Acad Sci U S A. 2005. PMID: 16339909 Free PMC article.
-
Covariance of charged amino acids at positions 322 and 440 of HIV-1 Env contributes to coreceptor specificity of subtype B viruses, and can be used to improve the performance of V3 sequence-based coreceptor usage prediction algorithms.PLoS One. 2014 Oct 14;9(10):e109771. doi: 10.1371/journal.pone.0109771. eCollection 2014. PLoS One. 2014. PMID: 25313689 Free PMC article.
-
Induction of neutralizing antibodies against tier 2 human immunodeficiency virus 1 in rhesus macaques infected with tier 1B simian/human immunodeficiency virus.Arch Virol. 2019 May;164(5):1297-1308. doi: 10.1007/s00705-019-04173-5. Epub 2019 Feb 28. Arch Virol. 2019. PMID: 30820667 Free PMC article.
-
Hybrid approach for predicting coreceptor used by HIV-1 from its V3 loop amino acid sequence.PLoS One. 2013 Apr 15;8(4):e61437. doi: 10.1371/journal.pone.0061437. Print 2013. PLoS One. 2013. PMID: 23596523 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous